These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25572554)

  • 1. Prostanoids in allergy.
    Honda T; Kabashima K
    Allergol Int; 2015 Jan; 64(1):11-6. PubMed ID: 25572554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostanoid receptors as possible targets for anti-allergic drugs: recent advances in prostanoids on allergy and immunology.
    Honda T; Tokura Y; Miyachi Y; Kabashima K
    Curr Drug Targets; 2010 Dec; 11(12):1605-13. PubMed ID: 20735353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of selected prostanoid receptors as targets in a new therapeutic strategy for allergy and immune diseases.
    Kabashima K; Tokura Y
    Curr Drug Saf; 2007 Sep; 2(3):186-92. PubMed ID: 18690966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostanoids in the cutaneous immune response.
    Kabashima K; Miyachi Y
    J Dermatol Sci; 2004 May; 34(3):177-84. PubMed ID: 15113587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis.
    Arai I; Takano N; Hashimoto Y; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakaike S
    Eur J Pharmacol; 2004 Nov; 505(1-3):229-35. PubMed ID: 15556157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
    Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
    Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity.
    Kabashima K
    J Dermatol Sci; 2013 Apr; 70(1):3-11. PubMed ID: 23473856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammation-allergy and prostanoids. (2). The role of prostanoids in allergic inflammation].
    Tanaka H; Nagai H
    Nihon Yakurigaku Zasshi; 2001 Apr; 117(4):262-6. PubMed ID: 11338375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptors in allergic diseases.
    Castan L; Magnan A; Bouchaud G
    Allergy; 2017 May; 72(5):682-690. PubMed ID: 27864967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The research for atopic dermatitis: up to date].
    Yokozeki H
    Nihon Rinsho; 2014 Aug; 72(8):1503-9. PubMed ID: 25167760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filaggrin degradation by caspase-14 is required for UVB photoprotection but does not influence allergic sensitization in a mouse model of atopic dermatitis.
    Devos M; Prawitt J; Staumont-Salle D; Hoste E; Fleury S; Bouchaert E; Gilbert B; Lippens S; Vandenabeele P; Dombrowicz D; Declercq W
    J Invest Dermatol; 2012 Dec; 132(12):2857-60. PubMed ID: 22931922
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostanoids and leukotrienes in the pathophysiology of atopic dermatitis and psoriasis.
    Honda T; Kabashima K
    Int Immunol; 2019 Aug; 31(9):589-595. PubMed ID: 30715370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased scratching counts depend on a decrease in ability of cutaneous prostaglandin D2 biosynthesis in NC/Nga mice with atopic dermatitis.
    Sugimoto M; Arai I; Futaki N; Hashimoto Y; Honma Y; Nakaike S
    Exp Dermatol; 2005 Dec; 14(12):898-905. PubMed ID: 16274457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-31: a new link between T cells and pruritus in atopic skin inflammation.
    Sonkoly E; Muller A; Lauerma AI; Pivarcsi A; Soto H; Kemeny L; Alenius H; Dieu-Nosjean MC; Meller S; Rieker J; Steinhoff M; Hoffmann TK; Ruzicka T; Zlotnik A; Homey B
    J Allergy Clin Immunol; 2006 Feb; 117(2):411-7. PubMed ID: 16461142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiopathogenesis of atopic dermatitis--an overview.
    Pastar Z; Lipozencić J; Ljubojević S
    Acta Dermatovenerol Croat; 2005; 13(1):54-62. PubMed ID: 15788148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH in Atopic Dermatitis.
    Danby SG; Cork MJ
    Curr Probl Dermatol; 2018; 54():95-107. PubMed ID: 30130778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
    Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
    Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course changes of scratching counts, dermatitis symptoms, and levels of cutaneous prostaglandins in NC/Nga mice.
    Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
    Exp Dermatol; 2006 Nov; 15(11):875-82. PubMed ID: 17002684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors.
    Hubertus K; Mischnik M; Timmer J; Herterich S; Mark R; Moulard M; Walter U; Geiger J
    Eur J Pharmacol; 2014 Oct; 740():15-27. PubMed ID: 25003953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functions of prostaglandin receptors in contact dermatitis and application to drug discovery].
    Morimoto K; Tsuchiya S; Sugimoto Y
    Yakugaku Zasshi; 2012; 132(11):1217-23. PubMed ID: 23123710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.